Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors
Clinical trial NCT02267967 · COMPLETED
Trial details
- NCT number
- NCT02267967
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-31
- Primary completion
- 2017-08-23
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.